BLINCYTO (blinatumomab) for injection
BLINCYTO for injection is indicated to treat certain types of acute lymphoblastic leukemia (ALL).
| Brand Name: | BLINCYTO |
| Generic Name: | blinatumomab for injection |
| Strength: | For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution. |
| Manufacturer: | Amgen Inc |
| Approved By: | EMA, USFDA |
Source content : www.accessdata.fda.gov
Get Access to BLINCYTO (blinatumomab) for injection in India
To know the best price of the BLINCYTO (blinatumomab) for injection available with Lucknow Speciality Pharma call at Contact No. M: 9336559090 or WhatsApp at 9336559090 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Contact Details
Contact Person: Jitender Mishra
Company: Lucknow Speciality Pharma
Address: 2nd Floor, 207-A, Felix Square, Golf City, Gomti Nagar, Lucknow, Uttar Pradesh 226030
Phone: 9336559090, 9760014849
WhatsApp: 9336559090, 9760014849
Email: info@lucknowpharma.com
Get Access To BLINCYTO (blinatumomab) for injection
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal
What is the use of blinatumomab for injection?
Blinatumomab was originally approved to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults and children. It is approved by the US Food and Drug Administration (FDA) for B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease greater than or equal to 0.1% as well as relapsed or refractory B-cell precursor ALL.
Has BLINCYTO (blinatumomab) been launched in India?
Patient Access Facilitation for BLINCYTO (blinatumomab)
To give request - contact sourcing facilitation team
Company Name: Lucknow Speciality pharma
NEWS / UPDATES
- FDA approves blinatumomab as consolidation for CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia
- FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
- FDA granted accelerated approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia
- FDA Approval: Blinatumomab
FAQs
How to Access BLINCYTO in India?
What is the role of Lucknow Speciality Pharma?
- Processing regulatory documentation and CDSCO import permit filings (Form 12A/12B).
- Coordinating customs clearance and end-to-end import formalities.
- Managing GDP-compliant, temperature-controlled cold-chain logistics for direct delivery to hospitals or individual patients.
How much do BLINCYTO (blinatumomab) for injection cost in Lucknow, India?
Where does The Lucknow Speciality Pharma supply medicines and medical products?
Key Metropolitan & Regional Delivery Hubs:
- Delhi (NCR): Delhi, Gurugram, Noida, Greater Noida, Ghaziabad.
- Uttar Pradesh: Lucknow, Kanpur, Prayagraj, Varanasi, Agra, Meerut, Bareilly, Gorakhpur, Aligarh, Moradabad, Jhansi, Mathura–Vrindavan, Ayodhya, and surrounding districts.
- Eastern & Central India: Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga (Bihar); Ranchi (Jharkhand); Bhopal, Indore (Madhya Pradesh); Raipur (Chhattisgarh); Jaipur (Rajasthan); Dehradun (Uttarakhand).
- Expanded Regional Coverage: Guwahati (Assam), Agartala (Tripura), Imphal (Manipur), Kolkata, Siliguri, Asansol (West Bengal), and Nepal.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
+91 93365 59090
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
For Hospitals and Clinics:
"Hospitals and clinics in Lucknow can now avail exclusive discounts on bulk medicine orders. Lucknow Speciality Pharma offers the best pharmaceutical deals—call us today to get updated offers on minimum order quantities!"
For Retail Customers:
"Looking for affordable medicines in Lucknow? Lucknow Speciality Pharma offers special discounts on a wide range of medicines. Call now to discover our latest offers available with a minimum purchase!"





